Observational, Long-term Extension Study for Participants of Prior VY-AADC01 Studies

Neurocrine Biosciences

Status: Completed

Conditions: Parkinson's Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT03733496

PD-1104

Details and patient eligibility

About

An extension study for participants who have completed a prior VY-AADC01 clinical study

Enrollment: 14 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

1. Completed participation in the PD-1101 or PD-1102 clinical study of VY-AADC01 gene therapy

Key Exclusion Criteria:

None

Trial design

14 participants in 1 patient group

Participants from VY-AADC01 clinical studies:

Description:

Participants who have completed participation in VY-AADC01 clinical studies (PD-1101 or PD-1102) will be invited to participate in this extension study